2013 Archived Content
The Evidence-Based Reimbursement Summit is comprised of back-to-back conferences, Generating Evidence for Reimbursement Decisions: Therapeutics, and Generating Evidence for Reimbursement Decisions: Diagnostics. As such, this is the only reimbursement-focussed conference that brings together an international audience of C-Level executives from both Pharma and Diagnostics. At the 2012 Summit, 70% of all delegates were director level or higher, making this the ideal Summit for those seeking the highest level networking and collaborative opportunities, while also hearing the latest insights and strategies from our esteemed speaker faculty.
Featured Speakers
J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, Evidera
Josephine Sollano, Dr.P.H., Vice President, Health Economics and Outcomes Research and Medical Communications, Oncology Business Unit, Pfizer Inc.
Mark J. Cziraky, Pharm.D., Vice President, Industry Sponsored Research, Healthcore
Featured Speakers
Elaine K. Jeter, M.D., J1 MolDx Medical Director, Palmetto GBA
Roger Klein, M.D., J.D., Department of Molecular Pathology, Cleveland Clinic Foundation
Jerry Conway, Vice President, Reimbursement & Payer Strategy, Foundation Medicine, Inc.
Short Courses
Clinical Studies for the Development of Evidence-Based Diagnostics
Reimbursement of Cancer Genomic Analysis
&
About the Summit
Cambridge Healthtech Institute (CHI) and the BioPharma Strategy Series bring Executive Decision Making 2013 to Bethesda, MD. The executive forum is made up of six co-located conferences, each serving leaders from Pharma, Biotech, Device, Diagnostic, CRO, Life Science Consulting and Technology companies.
Click here to download the Conference at a Glance